The future looks bright for Novabay Pharmaceuticals Inc (NBY) Stock

Ladenburg Thalmann raised the price target for the Novabay Pharmaceuticals Inc (AMEX:NBY) stock to “a Buy”. The rating was released on September 18, 2019, according to finviz. The research report from Laidlaw has reiterated the stock to Buy, with a price target set at $8. The stock was initiated by ROTH Capital, who disclosed in […]

A Tale from the Dusty Corner: Novabay Pharmaceuticals Inc (NBY) Stock

Ladenburg Thalmann raised the price target for the Novabay Pharmaceuticals Inc (AMEX:NBY) stock to “a Buy”. The rating was released on September 18, 2019, according to finviz. The research report from Laidlaw has reiterated the stock to Buy, with a price target set at $8. The stock was initiated by ROTH Capital, who disclosed in […]

Facts about Novabay Pharmaceuticals Inc (NBY) Stock that you might not know

Ladenburg Thalmann raised the price target for the Novabay Pharmaceuticals Inc (AMEX:NBY) stock to “a Buy”. The rating was released on September 18, 2019, according to finviz. The research report from Laidlaw has reiterated the stock to Buy, with a price target set at $8. The stock was initiated by ROTH Capital, who disclosed in […]

Novabay Pharmaceuticals Inc (NBY) Stock to return to profitability in the near future

Ladenburg Thalmann raised the price target for the Novabay Pharmaceuticals Inc (AMEX:NBY) stock to “a Buy”. The rating was released on September 18, 2019, according to finviz. The research report from Laidlaw has reiterated the stock to Buy, with a price target set at $8. The stock was initiated by ROTH Capital, who disclosed in […]